Provided by Tiger Trade Technology Pte. Ltd.

Corbus Pharmaceuticals

7.26
0.0000
Post-market: 7.22-0.0365-0.50%19:58 EDT
Volume:992.85K
Turnover:7.16M
Market Cap:140.42M
PE:-1.19
High:7.38
Open:7.26
Low:7.03
Close:7.26
52wk High:20.56
52wk Low:6.33
Shares:19.34M
Float Shares:17.42M
Volume Ratio:0.30
T/O Rate:5.70%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.0889
EPS(LYR):-5.9000
ROE:-95.58%
ROA:-53.00%
PB:1.37
PE(LYR):-1.23

Loading ...

Mizuho Securities Cuts Price Target on Corbus Pharmaceuticals to $34 From $44, Maintains Outperform Rating

MT Newswires Live
·
Jun 23

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jun 19

Analysts Offer Insights on Healthcare Companies: Ascendis Pharma (ASND) and Corbus Pharmaceuticals (CRBP)

TIPRANKS
·
Jun 18

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Jun 18

Oppenheimer Adjusts PT on Corbus Pharmaceuticals to $52 From $54, Maintains Outperform Rating

MT Newswires Live
·
Jun 17

Corbus Pharmaceuticals Holdings : Oppenheimer Cuts Target Price to $52 From $54

THOMSON REUTERS
·
Jun 17

Corbus Pharmaceuticals Holdings Inc. Stock Rises Monday, Still Underperforms Market

Dow Jones
·
Jun 16

Corbus Pharmaceuticals Holdings Inc. Stock Rises Thursday, Still Underperforms Market

Dow Jones
·
Jun 12

Corbus Pharma director Winston Kung reports disposal of 2,026 common shares worth $16,026.85

Reuters
·
Jun 12

Corbus Pharma director Anne Altmeyer disposes of 2,412 shares worth $19,085.82

Reuters
·
Jun 12

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Jun 10

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
Jun 06

Corbus Pharmaceuticals Holdings Inc. Stock Climbs 8.5%, Outperforms Peers

Dow Jones
·
Jun 05

Top Corbus Pharmaceuticals Executive Quietly Makes a Bold Insider Move

TIPRANKS
·
Jun 04

Corbus Chief Business Officer Nishant Saxena acquires $101,115 of common shares

Reuters
·
Jun 04

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
Jun 03

Corbus Pharmaceuticals (CRBP) Gets a Buy from Guggenheim

TIPRANKS
·
Jun 02

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Jun 02

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Jasper Therapeutics (JSPR) and Corbus Pharmaceuticals (CRBP)

TIPRANKS
·
Jun 02

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 30